Mindfulness Meditation as Adjunctive Therapy to Improve the Glycemic Care and Quality of Life in Patients with Type 1 Diabetes.
Med Sci (Basel). 2021 May 21 ;9(2). Epub 2021 May 21. PMID: 34064218
BACKGROUND: Mindfulness Meditation (MM) is known to improve glycemic control and enhance the quality of life (QoL) in type 2 diabetes (T2D) patients. Unfortunately, the role of meditation in type 1 diabetes (T1D) has not been studied extensively. Therefore, we conducted this study to determine the effect of MM on the glycemic control and QoL in people living with T1D.
METHODOLOGY: Thirty-two adults living with T1D were equally randomized into intervention (meditation) and control groups. The glycemic control and QoL were assessed at the baseline and after six months of intervention.
RESULTS: A total of thirty-two adults (15 males, 46.9%; mean age 23.8± 6.6 years) with type 1 diabetes (mean diabetes duration 12.7 ± 6.2 years) participated in the study. At the end of six months, a statistically significant improvement was seen in the mean blood glucose level in the control group (222.4 ± 77.8 versus 182.6 ± 52.0;= 0.007) and the intervention group (215.3± 50.1 versus 193.2± 31.8;= 0.008). Additionally, there was a significant reduction in the total diabetes distress score in the intervention group (1.6± 0.3 versus 1.3 ± 0.3;= 0.003), while no change was observed in the control group (1.6± 0.7 versus 1.7 ± 0.4;= 0.762). A statistically significant improvement was noticed in the health and functioning domain in the intervention group (= 0.023).
CONCLUSIONS: An improvement in the glycemic control and quality of life of the patients was observed in our study. MM certainly plays an important role in attaining peace of mind and helps patients to channel their energy in a positive direction.